14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Fatty Liver, Nonalcoholic in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G | 1 |
| Xu, R | 1 |
| Zhang, S | 1 |
| Wang, Y | 1 |
| Wang, P | 1 |
| Edin, ML | 1 |
| Zeldin, DC | 1 |
| Wang, DW | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Topics: 8,11,14-Eicosatrienoic Acid; Alanine Transaminase; Animals; Aspartate Aminotransferases; Catalase; C | 2015 |